Following meta-analysis of CHD GWAS, we discovered that rs3918226*T of NOS3 (OR: 1.04, 95% CI: 1.03–1.06), rs6504218*G of PECAM1 (OR: 1.02, 95% CI: 1.01–1.02), and rs7623687*A of RHOA (OR: 1.03, 95% CI: 1.02–1.03) were significantly associated with increased CHD risk (Table S2). Here, PECAM1 is linked to coronary artery disorder.